EXCEMED, in collaboration with the European Charcot Foundation (ECF) and AcademicCME, is planning a Virtual Course to be held prior to the ECTRIMS Congress.
The 2021 Joint Pre-ECTRIMS Live Online Workshop is endorsed by ECTRIMS and ESNR.
This live, Online Programme will take place at 15.00 (CEST), on both 11th & 12th October, 2021. International experts will address the main scientific breakthroughs in the field and will provide practical suggestions for managing patients in clinical practice.
For further information please contact
Alessia Addessi email@example.com
Nicole McMenamin firstname.lastname@example.org
Chelsey Benedek email@example.com
Understanding and cure of Multiple Sclerosis is rapidly improving through the wide application of new technologies. They are used in all MS fields, like development of biomarkers, sophisticated imaging techniques of central nervous system, new drugs with innovative targets as well as new tools for remote patients monitoring.
The recent COVID-19 pandemic has boosted these processes that were already in place in MS in the past years. Nevertheless, the pandemic has also highlighted the need of new information and deep knowledge about the impact of viruses on immunocompromised hosts, such as MS patients, and of vaccines.
There are still many controversial themes, such as how to manage progressive MS patients, that are currently debated among neurologists and neuroscientists involved in MS field.
This workshop aims to provide updated scientific insights on the world of contemporary MS. International experts will address the main scientific breakthroughs in the field and will provide practical suggestions for managing patients in clinical practice.
- Describe new methods to measure cortical damage and disease severity in MS
- Illustrate mechanisms of action and safety profile of new MS treatments
- Describe emerging environmental factors influencing MS development
- Discuss how to manage vaccines in immunosuppressed MS patients
AGENDA - Day 1 - October 11th, 2021
15.00-15.10 Welcome & Opening
Session 1: UNDERSTANDING MULTIPLE SCLEROSIS
15.10-15.30 Emerging environmental factors triggering MS: the gut-brain axis
S. Baranzini, US
15.30-15.50 Immunosenescence and MS
Session 2: TREATING MULTIPLE SCLEROSIS
16.05-16.25 Present and future of treating relapsing
MS F. Lublin, US
16.25-16.45 Present and future of treating progression
G. Comi, Italy
16.55-17.15 Enhancing recovery: new approaches
L. Leocani, Italy
17.15-17.35 MS and demyelinating diseases in children
B. Banwell, US
Session 3: MONITORING MULTIPLE SCLEROSIS
17.50-18.10 Updated Role of MRI in Monitoring MS
F. Barkhof, the Netherlands
18.10-18.30 Diagnosis and monitoring of cognitive functions in MS
I.K. Penner, Germany
18.45-19.30 Panel Discussion on “Lesson learned from COVID-19”
C. Harris, Canada
A. Perrin Ross, USA
M.A. Robles Sanchez, Spain
19.30 End of Day 1
AGENDA - Day 2 - October 12th, 2021
Session 4: PATIENT REPORTED OUTCOMES: NEW PERSPECTIVES
15.00-15.20 The PROMS initiative
P. Zaratin, Italy
15.20-15.40 Research, validation and development
P. Vermersch, France
15.40-16.00 Role in clinical management
R. McBurney, US
Session 5: MS CONTROVERSIES 2021- THE FUTURE OF MS CARE
16.25-16.45 New evidence on the role of oligodendrocytes and OPCs in MS
C. Lubetzki, France
16.45-17.05 Moving fluid biomarkers into the clinic
M. Comabella, Spain
J. Kuhle, Switzerland
17.05-18.00 Round Table: MS care in this and the next pandemic: transcontinental perspective
J. Correale, Argentina
A. Cross, US
G. Giovannoni, UK
18.15-18.30 Wrap up and closing remarks
18.30 End of the workshop
This continuing education activity has been approved by the International Council of Nurses (ICN) for the award of International Continuing Nursing Education Credits (ICNECs). This educational programme has also been submitted for CME accreditation to the European Accreditation Council for Continuing Medical Education (EACCME®).
This educational activity is made possible thanks to unrestricted educational grants from BMS, Janssen and Sanofi Genzyme.